US EditionApple will avoid ban by selling latest Apple Watches without blood oxygen feature
- Apple is removing a blood oxygen monitoring feature from two Apple Watch models in the US due to a legal battle over patents.
- Analysts predicted that Apple would remove the feature instead of pulling devices from sale in the US.
- Apple will sell the affected models without the blood oxygen feature in the US.
44 Articles
44 Articles
Apple to disable blood-oxygen feature on premium watches sold in US as part of patent dispute
Cupertino, January 17, 2024 – Apple says it will disable a blood-oxygen monitoring feature on its two most popular watches in the U.S. beginning Thursday to comply with a court-ordered revival of a sales ban stemming from a patent dispute. The decision to turn off the blood-oxygen sensor for consumers who buy either the Apple Watch Series 9 or Ultra 2 in the U.S. came after a federal appeals court on Wednesday refused to extend an order that had…
Apple Watches go on sale without blood oxygen sensor amid patent dispute
Apple plans to sell its Series 9 and Ultra 2 Apple Watches without blood oxygen sensors after a federal court denied its bid to continue sales while it appeals an import ban imposed on those watches due to a patent infringement dispute with medical monitoring technology firm Masimo. Last year, the U.S. International Trade Commission (USITC) ruled that Apple’s blood oxygen sensors in those two smartwatches violated Masimo’s patents. The USITC imp…
Coverage Details
Bias Distribution
- 49% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
